Skip to content
InsiderTrades
SIGMA
Analysis
Recommendations
TOP
Basket
NEW
Terminal
NEW
Companies
Executives
Performance
Blog
GB
EN
GB
EN
Insiders
Trades
Sigma
US-Listed Companies · SEC (Form 4) · InsiderTrades Sigma · page 105
US
US
11,059 companies
US-Listed Companies
Regulator: SEC (Form 4).
IRSA INVESTMENTS & REPRESENTATIONS INC
— · 1.3bn
ISABELLA BANK Corp
Finance & Banque · 287m
ISLE OF CAPRI CASINOS INC
— · 21k
ISQ Open Infrastructure Co LLC
—
ISRAMCO INC
—
ISTAR INC.
Immobilier
ISTAR INC.
Immobilier
ISUN, INC.
Énergie
ITC Holdings Corp.
—
ITERIS, INC.
Industrie
ITG, Inc./DE/
— · 1.7bn
Previous
1
...
100
...
103
104
105
106
107
...
110
120
130
140
...
222
Next
ITRON INC /WA/
— · 3.8bn
ITRON, INC.
Énergie · 3.8bn
ITT EDUCATIONAL SERVICES INC
— · 959
ITT INC.
Industrie · 17bn
IVERIC bio, Inc.
Santé & Pharma
IX Acquisition Corp.
— · 78m
IXIA
—
IZEA Worldwide, Inc.
Médias & Communication · 76m
Ibotta, Inc.
Distribution & Commerce · 718m
Icahn Enterprises L.P.
Services aux entreprises · 5bn
Ichor Holdings, Ltd.
Industrie · 3.2bn
Iconic Sports Acquisition Corp.
—
Iconix Brand Group, INC.
Industrie · 3.3m
Icosavax, Inc.
Santé & Pharma
Idaho Strategic Resources, Inc.
Chimie & Matériaux · 604m
Ideal Power Inc.
Technologie · 73m
Ideanomics, INC.
Industrie
Identiv, Inc.
Technologie · 70m
Idera Pharmaceuticals, INC.
Santé & Pharma
Idexx Laboratories INC /de
Santé & Pharma · 44bn
Ignyta, Inc.
— · 1.8bn
Ikena Oncology, Inc.
Santé & Pharma
Illinois Tool Works INC
Industrie · 71bn
Illumina, INC.
Santé & Pharma · 29bn
Image Sensing Systems INC
Industrie
ImageneBio, Inc.
— · 69m
Imageware Systems INC
Technologie · 35k
Imago BioSciences, Inc.
Santé & Pharma
Immersion CORP
Technologie · 223m
Immix Biopharma, Inc.
Santé & Pharma · 791m
Immucell CORP
Santé & Pharma · 100m
Immune Design Corp.
— · 243m
Immune Therapeutics, Inc.
Santé & Pharma
Immuneering Corp
Santé & Pharma · 334m
Immunic, INC.
Santé & Pharma · 165m
ImmunityBio, Inc.
Santé & Pharma · 8.2bn
ImmunoGen, Inc.
Santé & Pharma
Immunocore Holdings plc
— · 1.6bn
Immunome Inc.
Santé & Pharma · 2.6bn